A draft of President Donald Trump’s executive order on drug prices lists several proposals to lessen regulatory hurdles for the pharmaceutical industry, reports The New York Times. Here are four things… Read more »
The News: New FDA Commissioner Dr. Scott Gottlieb comes into office immediately confronted by a host of tough challenges: from budget concerns, drug prices, staffing issues and a nationwide opioid… Read more »
The News: The US Senate voted 57 to 42 on Tuesday (May 9, 2017) to confirm Scott Gottlieb, MD, as Food and Drug Administration (FDA) Commissioner. Gottlieb, who was nominated by… Read more »
The News: Lawmakers expanded instead of slashed the budget for the National Institutes of Health (NIH) in its bipartisan deal to fund the government earlier this week, essentially snubbing the… Read more »
Steve’s Take: Remember President Trump’s pre- and post-election promise, no, it sounded more like a guarantee, of “insurance for everybody?” Then last week, the Trump-backed House bill, when finally unveiled… Read more »
Steve’s Take: Six years after its passage, the Affordable Care Act has demonstrated it’s far from perfect. But replacing such an immense, complicated law on an accelerated schedule is presenting… Read more »
The News: Legislation to repeal Obamacare and replace major portions of the healthcare program will be unveiled after a 10-day US House of Representatives recess that begins this week, House… Read more »
The News: Humana Inc. (Louisville KY) said it will leave the commercial individual insurance business effective in 2018, including coverage offered on public exchanges under the Affordable Care Act, after being unable to… Read more »
The News: President Donald Trump supports Medicare drug price negotiations, his spokesman said last week, remarks that sent pharmaceutical stocks swinging again as investors tried to assess whether drugmakers will… Read more »
The News: Georgia Rep. Tom Price, President Trump’s choice for secretary of the Department of Health and Human Services, on Tuesday rejected conflict of interest and abuse of power accusations related to… Read more »
